Kristine Misund
Trondheim, 7030, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Lynch syndrome caused by SINE-VNTR-Alu-F retrotransposon insert in MSH6 confirmed after 20 years of testing: a case report and literature review.
Journal: Hereditary cancer in clinical practice
Published: June 03, 2025
T cell phenotype and clonality changes in myeloma patients with short overall survival.
Journal: JCI insight
Published: November 07, 2024
The Prognostic Potential of circRNAs in Multiple Myeloma: Insights From Whole Bone Marrow and Purified Plasma Cells.
Journal: Journal of cellular and molecular medicine
Published: September 11, 2024
Targeting proteostasis in multiple myeloma through inhibition of LTK.
Journal: Leukemia
Published: September 08, 2024
Progression of monoclonal gammopathy of undetermined significance to multiple myeloma is associated with enhanced translational quality control and overall loss of surface antigens.
Journal: Journal of translational medicine
Published: March 22, 2024
Cell surface marker heterogeneity in human myeloma cell lines for modeling of disease and therapy.
Journal: Scientific reports
Published: March 08, 2024
A patient with minimal myeloma treatment who survived for 20 years.
Journal: Haematologica
Published: June 14, 2023
IL-32 is induced by activation of toll-like receptors in multiple myeloma cells.
Journal: Frontiers in immunology
Published: November 25, 2022
The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells.
Journal: Oncotarget
Published: October 21, 2022
Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines.
Journal: Frontiers in oncology
Published: September 09, 2022
Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence.
Journal: Leukemia
Published: September 17, 2021
Last Updated: 09/26/2026